trending Market Intelligence /marketintelligence/en/news-insights/trending/Gde9n-xmKk89KgRV3QAnYg2 content esgSubNav
In This List

Sun Pharmaceutical appoints CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Sun Pharmaceutical appoints CFO

C. S. Muralidharan will become Sun Pharmaceutical Industries Ltd.'s CFO on June 19.

Muralidharan joins the company from Teva Pharmaceutical Industries Ltd., where he served as the regional controller of the Asia-Pacific region and country CFO of India.